Telesis Bio, Inc. (TBIO)
Telesis Bio has a market cap or net worth of $1.11 billion. The enterprise value is $1.12 billion.
The last earnings date was Thursday, May 11, 2023, after market close.
|Earnings Date||May 11, 2023|
Telesis Bio has 29.61 million shares outstanding. The number of shares has increased by 1.13% in one year.
|Shares Change (YoY)||+1.13%|
|Shares Change (QoQ)||+0.33%|
|Owned by Insiders (%)||37.39%|
|Owned by Institutions (%)||43.15%|
|EV / Earnings||n/a|
|EV / Sales||39.69|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 3.82, with a Debt / Equity ratio of 1.14.
|Debt / Equity||1.14|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -92.20% and return on invested capital (ROIC) is -77.50%.
|Return on Equity (ROE)||-92.20%|
|Return on Assets (ROA)||-52.10%|
|Return on Capital (ROIC)||-77.50%|
|Revenue Per Employee||$126,076|
|Profits Per Employee||-$208,054|
In the past 12 months, Telesis Bio has paid $21,000 in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -55.31% in the last 52 weeks.
|52-Week Price Change||-55.31%|
|50-Day Moving Average||2.55|
|200-Day Moving Average||1.94|
|Average Volume (30 Days)||2,912,959|
Short Selling Information
The latest short interest is 225,986, so 0.76% of the outstanding shares have been sold short.
|Short Previous Month||182,749|
|Short % of Shares Out||0.76%|
|Short % of Float||2.55%|
|Short Ratio (days to cover)||3.04|
In the last 12 months, Telesis Bio had revenue of $28.12 million and -$46.40 million in losses. Loss per share was -$1.57.
|Loss Per Share||-$1.57|
The company has $32.24 million in cash and $41.72 million in debt, giving a net cash position of -$9.47 million or -$0.32 per share.
|Cash & Cash Equivalents||32.24M|
|Net Cash Per Share||-$0.32|
|Equity / Book Value||36.62M|
|Book Value Per Share||1.24|
In the last 12 months, operating cash flow was -$44.26 million and capital expenditures -$4.48 million, giving a free cash flow of -$48.74 million.
|Operating Cash Flow||-44.26M|
|Free Cash Flow||-48.74M|
|FCF Per Share||-$1.64|
Gross margin is 58.08%, with operating and profit margins of -158.83% and -165.02%.
Dividends & Yields
Telesis Bio does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|